Company intelligence / Profile preview

Vita Green Pharmaceutical (H.K.)

Hong Kong, Hong Kong

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

Vita Green's main clinical results are focused on herbal supplement safety and efficacy, including preclinical and clinical studies for selected products, but they do not run drug development or clinical trials in the conventional pharma sense; they routinely collaborate with academic experts and labs for these studies

Therapeutic areas: ImmunologyInfectious DiseasesDermatologyOther
Modalities: Herbal medicineSmall molecule (vitamin/mineral supplements)
Industry: Food & Nutrition

Partnerships

Universities and institutes in Hong Kong, China, Europe, and North America for R&D collaboration (including CUHK, Hong Kong Medical Museum sponsorship)

Beyond the preview

Go deeper on Vita Green Pharmaceutical (H.K.).

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vita Green Pharmaceutical (H.K.).

Explore the full profile